The latest recommendations of the CDC and the US Preventive Services Task Force, which are in turn based upon evidence that earlier initiation of ART (when CD4 counts are between 200 and 500×106/L), is associated with reduced risk for AIDS-related events or deaths [30], [32], suggests that broader, more inclusive testing is the direction Canada should be taking. This evidence concerns the gene CD4 and AIDS.